Healthcare [ 13/13 ] | Medical Devices [ 113/164 ]
NYSE | Common Stock
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.
It operates through two segments, Life Science and Clinical Diagnostics.
The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets.
It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories.
The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers.
Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 14, 24 | 0.00 Decreased by -100.00% | 2.99 Decreased by -100.00% |
| Feb 29, 24 | 3.10 Decreased by -6.34% | 2.84 Increased by +9.15% |
| Oct 26, 23 | 2.33 Decreased by -10.38% | 2.76 Decreased by -15.58% |
| Aug 3, 23 | 3.00 Decreased by -11.24% | 2.64 Increased by +13.64% |
| May 4, 23 | 3.34 Decreased by -32.39% | 3.63 Decreased by -7.99% |
| Feb 16, 23 | 3.31 Increased by +3.12% | 3.48 Decreased by -4.89% |
| Oct 27, 22 | 2.60 Decreased by -29.92% | 2.70 Decreased by -3.70% |
| Jul 28, 22 | 3.38 Decreased by -4.52% | 2.72 Increased by +24.26% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 24 | 610.82 M Decreased by -9.75% | 383.92 M Increased by +456.71% | Increased by +62.85% Increased by +516.88% |
| Dec 31, 23 | 681.18 M Decreased by -6.72% | 349.71 M Decreased by -58.04% | Increased by +51.34% Decreased by -55.02% |
| Sep 30, 23 | 632.12 M Decreased by -7.15% | 106.26 M Increased by +164.70% | Increased by +16.81% Increased by +169.68% |
| Jun 30, 23 | 681.11 M Decreased by -1.45% | -1.16 B Decreased by -25.35% | Decreased by -170.64% Decreased by -27.19% |
| Mar 31, 23 | 676.84 M Decreased by -3.32% | 68.96 M Increased by +102.05% | Increased by +10.19% Increased by +102.12% |
| Dec 31, 22 | 730.29 M Decreased by -0.34% | 833.49 M Increased by +152.97% | Increased by +114.13% Increased by +153.15% |
| Sep 30, 22 | 680.80 M Decreased by -8.87% | -164.23 M Decreased by -104.18% | Decreased by -24.12% Decreased by -104.59% |
| Jun 30, 22 | 691.10 M Decreased by -3.47% | -927.18 M Decreased by -201.43% | Decreased by -134.16% Decreased by -205.07% |